ACRO Statements on Innovation

The expertise and innovation of ACRO member companies helps speed the clinical trial
process and the development of safe and effective therapies. See below for ACRO’s statements on innovation.

Risk Based Quality Management (RBQM) – A Collaborative Approach to Holistic Clinical Trial Oversight

ACRO’s CRO Forum’s paper enables greater collaboration and efficiency through a shared vision of risk based quality management (RBQM).

Fullscreen Mode

Establishing Risk-Based Monitoring within a Quality-Based System as “Best Practice” for Clinical Studies

A survey of ACRO members reveals that Risk-Based Monitoring (RBM) makes clinical trial quality review more efficient and effective.

Fullscreen Mode

ACRO’s Considerations on Monitoring During COVID-19

On 13 March 2020, ACRO released a list of considerations that support clinical trial monitoring oversight during COVID-19.

Fullscreen Mode